ABSTRACT
Points in Synthesis ...............................................................................................................193 11.3.1 Preliminary Selection of Suitable Blocking Group .................................................193 11.3.2 Penicillin G and Its Rearrangement to
4-Thia-2,6-Diazabicyclo[3.2.0]hept-2-enes..............................................................194 11.3.3 Optically Active 2-Acetyl-THF................................................................................195 11.3.4 Thiazole Side Chain, ATMAA, and Activated Derivative, DAMA ........................196
